{"count": 111, "results": [{"_id": "34192893", "pmid": 34192893, "pmcid": "PMC8478091", "title": "Long-Term Incidence of Stroke and Dementia in ASCOT", "journal": "Stroke", "authors": ["Whiteley WN", "Gupta AK", "Godec T", "Rostamian S", "Whitehouse A", "Mackay J", "Sever PS"], "date": "2021-10-01T00:00:00Z", "doi": "10.1161/STROKEAHA.120.033489", "meta_date_publication": "2021 Oct", "meta_volume": "52", "meta_issue": "10", "meta_pages": "3088-3096", "score": 50257.22, "text_hl": "The @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@-based BP-lowering regimen compared with the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@-based regimen significantly reduced all @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ (HR, 0.77 [95% CI, 0.66-0.89]; P=0.0003) after a median follow-up of 5.5 years.", "citations": {"NLM": "Whiteley WN, Gupta AK, Godec T, Rostamian S, Whitehouse A, Mackay J, Sever PS. Long-Term Incidence of Stroke and Dementia in ASCOT Stroke. 2021 Oct;52(10):3088-3096. PMID: 34192893", "BibTeX": "@article{34192893, title={Long-Term Incidence of Stroke and Dementia in ASCOT}, author={Whiteley WN and Gupta AK and Godec T and Rostamian S and Whitehouse A and Mackay J and Sever PS}, journal={Stroke}, volume={52}, number={10}, pages={3088-3096}}"}}, {"_id": "32802081", "pmid": 32802081, "pmcid": "PMC7416264", "title": "Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes", "journal": "Stem Cells Int", "authors": ["Satani N", "Giridhar K", "Cai C", "Wewior N", "Norris DD", "Aronowski J", "Savitz SI"], "date": "2020-08-01T00:00:00Z", "doi": "10.1155/2020/8894168", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "8894168", "score": 50251.625, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ had no effect on secretome in cocultures with @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@-Mo (Figure 3).", "citations": {"NLM": "Satani N, Giridhar K, Cai C, Wewior N, Norris DD, Aronowski J, Savitz SI. Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes Stem Cells Int. 2020;2020():8894168. PMID: 32802081", "BibTeX": "@article{32802081, title={Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes}, author={Satani N and Giridhar K and Cai C and Wewior N and Norris DD and Aronowski J and Savitz SI}, journal={Stem Cells Int}, volume={2020}, pages={8894168}}"}}, {"_id": "31898196", "pmid": 31898196, "title": "Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis.", "journal": "Am J Cardiovasc Drugs", "authors": ["Francischetti EA", "de Abreu VG", "da Silva Figueiredo LF", "Dezonne RS", "Coutinho ESF"], "date": "2020-10-01T00:00:00Z", "doi": "10.1007/s40256-019-00393-x", "meta_date_publication": "2020 Oct", "meta_volume": "20", "meta_issue": "5", "meta_pages": "447-470", "score": 50242.18, "text_hl": "Comparisons of two classes of drugs with at least two studies indicated that (1) CCB and ACEI increased the risk of @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@HF@@@ [relative risk (RR) = 2.26; 95% confidence interval (CI) 1.16-4.40] and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ [hazard ratio (HR) = 1.13; 1.00-1.26]), respectively, compared to diuretics; and (2) CCB showed a reduction in @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ (HR = 0.77; 0.66-0.89) and total mortality (HR = 0.94; 0.87-1.01) compared to the BB @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Francischetti EA, de Abreu VG, da Silva Figueiredo LF, Dezonne RS, Coutinho ESF. Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Oct;20(5):447-470. PMID: 31898196", "BibTeX": "@article{31898196, title={Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis.}, author={Francischetti EA and de Abreu VG and da Silva Figueiredo LF and Dezonne RS and Coutinho ESF}, journal={Am J Cardiovasc Drugs}, volume={20}, number={5}, pages={447-470}}"}}, {"_id": "2387213", "pmid": 2387213, "title": "Reduced total mortality and death from myocardial infarction and stroke in moderate/severe hypertensives treated with \"Tenormin\" (atenolol).", "journal": "Drugs Exp Clin Res", "authors": ["Cruickshank JM"], "date": "1990-01-01T00:00:00Z", "meta_date_publication": "1990", "meta_volume": "16", "meta_issue": "3", "meta_pages": "133-6", "score": 50066.277, "text_hl": "Reduced total mortality and @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ from @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ in moderate/severe @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensives@@@ treated with \"@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Tenormin@@@\" (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@).", "citations": {"NLM": "Cruickshank JM. Reduced total mortality and death from myocardial infarction and stroke in moderate/severe hypertensives treated with \"Tenormin\" (atenolol). Drugs Exp Clin Res. 1990;16(3):133-6. PMID: 2387213", "BibTeX": "@article{2387213, title={Reduced total mortality and death from myocardial infarction and stroke in moderate/severe hypertensives treated with \"Tenormin\" (atenolol).}, author={Cruickshank JM}, journal={Drugs Exp Clin Res}, volume={16}, number={3}, pages={133-6}}"}}, {"_id": "12585945", "pmid": 12585945, "title": "Losartan vs atenolol in prevention of stroke and cardiovascular disease.", "journal": "JAMA", "authors": ["Messerli FH", "Grossman E", "Fournier A"], "date": "2003-02-12T00:00:00Z", "doi": "10.1001/jama.289.6.700-b", "meta_date_publication": "2003 Feb 12", "meta_volume": "289", "meta_issue": "6", "meta_pages": "700-1; author reply 701", "score": 50066.01, "text_hl": "@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ vs @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in prevention of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ and @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@.", "citations": {"NLM": "Messerli FH, Grossman E, Fournier A. Losartan vs atenolol in prevention of stroke and cardiovascular disease. JAMA. 2003 Feb 12;289(6):700-1; author reply 701. PMID: 12585945", "BibTeX": "@article{12585945, title={Losartan vs atenolol in prevention of stroke and cardiovascular disease.}, author={Messerli FH and Grossman E and Fournier A}, journal={JAMA}, volume={289}, number={6}, pages={700-1; author reply 701}}"}}, {"_id": "12585946", "pmid": 12585946, "title": "Losartan vs atenolol in prevention of stroke and cardiovascular disease.", "journal": "JAMA", "authors": ["Fournier A", "Oprisiu R", "Andrejak M", "Fernandez L", "Achard JM"], "date": "2003-02-12T00:00:00Z", "doi": "10.1001/jama.289.6.700-a", "meta_date_publication": "2003 Feb 12", "meta_volume": "289", "meta_issue": "6", "meta_pages": "700; author reply 701", "score": 50065.46, "text_hl": "@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ vs @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in prevention of @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ and @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@.", "citations": {"NLM": "Fournier A, Oprisiu R, Andrejak M, Fernandez L, Achard JM. Losartan vs atenolol in prevention of stroke and cardiovascular disease. JAMA. 2003 Feb 12;289(6):700; author reply 701. PMID: 12585946", "BibTeX": "@article{12585946, title={Losartan vs atenolol in prevention of stroke and cardiovascular disease.}, author={Fournier A and Oprisiu R and Andrejak M and Fernandez L and Achard JM}, journal={JAMA}, volume={289}, number={6}, pages={700; author reply 701}}"}}, {"_id": "15530629", "pmid": 15530629, "title": "Atenolol in hypertension: is it a wise choice?", "journal": "Lancet", "authors": ["Carlberg B", "Samuelsson O", "Lindholm LH"], "date": "2004-11-06T00:00:00Z", "doi": "10.1016/S0140-6736(04)17355-8", "meta_date_publication": "2004 Nov 6-12", "meta_volume": "364", "meta_issue": "9446", "meta_pages": "1684-9", "score": 50065.3, "text_hl": "@<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@Stroke@@@ was also more frequent with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment. ", "citations": {"NLM": "Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet. 2004 Nov 6-12;364(9446):1684-9. PMID: 15530629", "BibTeX": "@article{15530629, title={Atenolol in hypertension: is it a wise choice?}, author={Carlberg B and Samuelsson O and Lindholm LH}, journal={Lancet}, volume={364}, number={9446}, pages={1684-9}}"}}, {"_id": "2429095", "pmid": 2429095, "title": "Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers.", "journal": "J Cardiovasc Pharmacol", "authors": ["Rosenkranz B", "Ledermann H", "Frölich JC"], "date": "1986-09-01T00:00:00Z", "doi": "10.1097/00005344-198609000-00010", "meta_date_publication": "1986 Sep-Oct", "meta_volume": "8", "meta_issue": "5", "meta_pages": "943-9", "score": 50064.457, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ significantly decreased systolic and diastolic blood pressure as well as heart rate; @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ volume index following exercise increased significantly, and cardiac index was unchanged. ", "citations": {"NLM": "Rosenkranz B, Ledermann H, Frölich JC. Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers. J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):943-9. PMID: 2429095", "BibTeX": "@article{2429095, title={Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers.}, author={Rosenkranz B and Ledermann H and Frölich JC}, journal={J Cardiovasc Pharmacol}, volume={8}, number={5}, pages={943-9}}"}}, {"_id": "17959026", "pmid": 17959026, "title": "Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats.", "journal": "Acta Pharmacol Sin", "authors": ["Ling G", "Liu AJ", "Shen FM", "Cai GJ", "Liu JG", "Su DF"], "date": "2007-11-01T00:00:00Z", "doi": "10.1111/j.1745-7254.2007.00630.x", "meta_date_publication": "2007 Nov", "meta_volume": "28", "meta_issue": "11", "meta_pages": "1755-60", "score": 50062.668, "text_hl": "Effects of combination therapy with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on blood pressure control and @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ prevention in @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@-prone spontaneously @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Ling G, Liu AJ, Shen FM, Cai GJ, Liu JG, Su DF. Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats. Acta Pharmacol Sin. 2007 Nov;28(11):1755-60. PMID: 17959026", "BibTeX": "@article{17959026, title={Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats.}, author={Ling G and Liu AJ and Shen FM and Cai GJ and Liu JG and Su DF}, journal={Acta Pharmacol Sin}, volume={28}, number={11}, pages={1755-60}}"}}, {"_id": "24750981", "pmid": 24750981, "title": "Atenolol vs nonatenolol beta-blockers for the treatment of hypertension: a meta-analysis.", "journal": "Can J Cardiol", "authors": ["Kuyper LM", "Khan NA"], "date": "2014-05-01T00:00:00Z", "doi": "10.1016/j.cjca.2014.01.006", "meta_date_publication": "2014 May", "meta_volume": "30", "meta_issue": "5 Suppl", "meta_pages": "S47-53", "score": 50062.54, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ is associated with increased @<m>DISEASE_Stroke</m> @DISEASE_MESH:D020521 @@@stroke@@@ in the elderly but whether this extends to nonatenolol beta-blockers remains uncertain.", "citations": {"NLM": "Kuyper LM, Khan NA. Atenolol vs nonatenolol beta-blockers for the treatment of hypertension: a meta-analysis. Can J Cardiol. 2014 May;30(5 Suppl):S47-53. PMID: 24750981", "BibTeX": "@article{24750981, title={Atenolol vs nonatenolol beta-blockers for the treatment of hypertension: a meta-analysis.}, author={Kuyper LM and Khan NA}, journal={Can J Cardiol}, volume={30}, number={5 Suppl}, pages={S47-53}}"}}]}